Evidence map›Paper›PMID 36441697›Full record

ArticlePloS one2022

A genetic approach to identify amino acids in Gcn1 required for Gcn2 activation.

Susanne Gottfried, Siaosi M B M J Koloamatangi, Clement Daube, Anja H Schiemann, Evelyn Sattlegger

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Construction of Yeast One-Hybrid Library ofJournal of fungi (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Susanne GottfriedSchool of Natural Sciences, Massey University, Auckland, New Zealand.
Siaosi M B M J KoloamatangiSchool of Natural Sciences, Massey University, Auckland, New Zealand.
Clement DaubeSchool of Natural Sciences, Massey University, Auckland, New Zealand.ORCID 0000-0003-0511-8297
Anja H SchiemannSchool of Natural Sciences, Massey University, Palmerston North, New Zealand.
Evelyn SattleggerSchool of Natural Sciences, Massey University, Auckland, New Zealand.ORCID 0000-0002-3144-2755
Massey University · NZMaurice Wilkins Centre · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The protein kinase Gcn2 is present in virtually all eukaryotic cells. It is best known for its role in helping cells cope with amino acid starvation. Under starvation, Gcn2 phosphorylates the α subunit of the eukaryotic translation initiation factor 2 (eIF2α), to stimulate a signal transduction pathway that allows cells to cope and overcome starvation. Gcn2 has been implicated in many additional biological functions. It appears that for all functions, Gcn2 must directly bind to its effector protein Gcn1, mediated via a region in Gcn1 called the RWD binding domain (RWDBD). Arg-2259 in this region is important for Gcn2 binding. Overexpression of a Gcn1 fragment only encompassing the RWDBD binds Gcn2, thereby disrupting endogenous Gcn1-Gcn2 interaction which dampens Gcn2 activation. Consequently, cells are unable to increase eIF2α phosphorylation under starvation conditions, visible by impaired growth. This dominant negative phenotype is reverted by the R2259A substitution, again allowing Gcn1-Gcn2 interaction and enhanced eIF2α phosphorylation. We have found that the amino acid substitutions, R2289A, R2297A, and K2301A, also reverted the dominant negative phenotype as well as allowed enhanced eIF2α phosphorylation, as found previously for the R2259A substitution. This suggests that the respective amino acids are relevant for the overexpressed RWDBD to disrupt Gcn1-Gcn2 interaction and impair Gcn2 activation, supporting the idea that in Gcn1 these amino acids mediate Gcn2-binding. Our findings suggest that two helices in Gcn1 constitute a Gcn2 binding site. We serendipitously found amino acid substitutions that enhanced the dominant negative phenotype that correlated with a further reduction in eIF2α-P levels, suggesting that the respective RWDBD variants are more potent in disrupting Gcn1-Gcn2 interaction.

Indexed as

Peptide Elongation FactorsProtein Serine-Threonine KinasesSaccharomyces cerevisiae ProteinsAmino AcidsAmino Acid SubstitutionEukaryotic Initiation Factor-2RNA-Binding ProteinsSaccharomyces cerevisiaeTrans-ActivatorsAmino AcidsEukaryotic Initiation Factor-2GCN1 protein, S cerevisiaeGCN2 protein, S cerevisiaePeptide Elongation FactorsProtein Serine-Threonine KinasesRNA-Binding ProteinsSaccharomyces cerevisiae ProteinsTrans-Activators

Identifiers

PMID36441697
PMCPMC9704636
OpenAlexW4310095249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.